Combination medications for alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether combining two medications—one that helps control cravings and one that affects appetite and reward—can help people reduce or stop drinking alcohol. If you are in treatment for alcohol use disorder收, this may offer a new way to support your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 65 years old.
- You need to be enrolled at Ashley Addiction Treatment center for at least one week before starting the study.
- You must have a diagnosis of alcohol use disorder (alcohol dependence).
- You need to be willing to use contraception (like condoms or birth control) if you can become pregnant.
- You cannot have certain medical conditions (like pancreatitis, gallbladder, liver, kidney, or parathyroid disease, or unmanaged diabetes).
- You must not have used opioids in the past 10 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
This study tests whether a ketone supplement affects how the brain uses energy and whether it can reduce alcohol cravings and drinking. If you drink regularly but aren't looking for treatment, you may be able to join.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This study tests whether starting certain medications in the emergency room can help people with moderate to severe alcohol use disorder reduce heavy drinking and withdrawal problems after they leave the ER. It compares outcomes for participants who receive the study medications soon after an ER visit.
This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.